Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Shu‐Mei Yan"'
Autor:
Xudong Wan, Yuantao Liu, Yiman Peng, Jian Wang, Shu‐mei Yan, Lu Zhang, Wanchun Wu, Lei Zhao, Xuelan Chen, Kexin Ren, Haicheng Long, Yiling Luo, Qin Yan, Lele Zhang, Dengzhi Lei, Pengpeng Liu, Shujun Li, Lihui Liu, Linjie Guo, Jiajia Du, Mengsha Zhang, Siqi Dai, Yi Yang, Hongyu Liu, Nianyong Chen, Jinxin Bei, Lin Feng, Yu Liu, Mu‐sheng Zeng, Chong Chen, Qian Zhong
Publikováno v:
Advanced Science, Vol 11, Iss 36, Pp n/a-n/a (2024)
Abstract Nasopharyngeal carcinoma (NPC), a squamous cell carcinoma originating in the nasopharynx, is a leading malignancy in south China and other south and east Asia areas. It is frequently associated with Epstein‐Barr virus (EBV) infection, whil
Externí odkaz:
https://doaj.org/article/3fddbbb323fe4a37ae102467f7a196f7
Autor:
Yutian Zou, Shaoquan Zheng, Xinhua Xie, Feng Ye, Xiaoqian Hu, Zhi Tian, Shu-Mei Yan, Lu Yang, Yanan Kong, Yuhui Tang, Wenwen Tian, Jindong Xie, Xinpei Deng, Yan Zeng, Zhe-Sheng Chen, Hailin Tang, Xiaoming Xie
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Anti-HER2 resistance causes treatment failure in HER2-positive breast cancers. Here the authors identify FGFR4 as one of the vulnerabilities of anti-HER2 resistant breast cancer and show that FGRR4 inhibition enhances sensitivity to anti-HER2 treatme
Externí odkaz:
https://doaj.org/article/12408df057f441a1b457230d76339115
Autor:
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, Si-Ying Peng, Cong Sun, Yanan Zuo, Lan-Yi Zhong, Shu-Mei Yan, Xiao Zhang, Ziqing Yang, Yong-Jian Peng, Xuanling Shi, Su-Mei Cao, Xinquan Wang, Mu-Sheng Zeng, Linqi Zhang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Currently, there are no treatments or vaccines against Epstein-Barr virus (EBV) infection. Here, Zhu et al. isolate gH/gL-specific antibodies from infected donors and identify 1D8, that substantially reduces infection levels in both, B- and epithelia
Externí odkaz:
https://doaj.org/article/2239cf6967614df582f09b6994a16020
Autor:
Zhang-Hua Chen, Shu-Mei Yan, Xi-Xi Chen, Qi Zhang, Shang-Xin Liu, Yang Liu, Yi-Ling Luo, Chao Zhang, Miao Xu, Yi-Fan Zhao, Li-Yun Huang, Bin-Liu Liu, Tian-Liang Xia, Da-Zhi Xu, Yao Liang, Yong-Ming Chen, Wei Wang, Shu-Qiang Yuan, Hui-Zhong Zhang, Jing-Ping Yun, Wei-Wei Zhai, Mu-Sheng Zeng, Fan Bai, Qian Zhong
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-22 (2021)
Abstract Background Epstein-Barr virus (EBV)-associated gastric carcinomas (EBVaGCs) present unique molecular signatures, but the tumorigenesis of EBVaGCs and the role EBV plays during this process remain poorly understood. Methods We applied whole-e
Externí odkaz:
https://doaj.org/article/de191290ceff45e7a3f8fac7226e025f
Autor:
Yan-Lin Wen, Shu-Mei Yan, Wei Wei, Xia Yang, Shi-Wen Zhang, Jing-Ping Yun, Li-Li Liu, Rong-Zhen Luo
Publikováno v:
Molecular Medicine, Vol 27, Iss 1, Pp 1-12 (2021)
Abstract Background Endocervical adenocarcinoma (ECA) is further classified as human papillomavirus (HPV)-associated (HPVA) or non-HPVA (NHPVA), per the International Endocervical Adenocarcinoma Criteria and Classification (IECC). HPVA is a glandular
Externí odkaz:
https://doaj.org/article/b55fdfd10a5f48d8aa7df2bf179ce67b
Autor:
Jing‐Sheng Cai, Shuo Li, Shu‐Mei Yan, Jie Yang, Mu‐Zi Yang, Chu‐Long Xie, Ji‐Bin Li, Yan‐Fen Feng, Hao‐Xian Yang, Xue Hou
Publikováno v:
Thoracic Cancer, Vol 12, Iss 9, Pp 1336-1346 (2021)
Abstract Background Major pathologic response (MPR) is mainly focused on residual viable tumor in the tumor bed regardless of lymph node. Herein, we investigated the predictive value of MPR and node status on survival in nonsmall‐cell lung cancer (
Externí odkaz:
https://doaj.org/article/887a0f5f490c4071bcb069286faa497d
Autor:
Shu-Mei Yan, Jiang-Ping Li, Chang-You Wu, Ming-Yuan Chen, Shang-Xin Liu, Yin-Feng Kang, Cong Sun, Jennifer R Grandis, Mu-Sheng Zeng, Qian Zhong
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the r
Externí odkaz:
https://doaj.org/article/9ea31ac4952542f9bea1a27c525694b2
Autor:
Ze-Xian Liu, Rui Sun, Jian-Ming Li, Sai-Lan Liu, Li-Juan Bian, Qiu-Yan Chen, Xue-Song Sun, Dong-Hua Luo, Xiao-Yun Li, Bei-Bei Xiao, Jin-Jie Yan, Zi-Jian Lu, Shu-Mei Yan, Li Yuan, Lin-Quan Tang, Hai-Qiang Mai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background The tumor immune microenvironment has clinicopathological significance in predicting prognosis and therapeutic efficacy. We aimed to develop an immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma (NPC).
Externí odkaz:
https://doaj.org/article/bf466c08ee5e46bd8df4c83559448883
Autor:
Run-Cong Nie, Shu-Qiang Yuan, Shi Chen, Shu-Mei Yan, Yong-Ming Chen, Xiao-Jiang Chen, Guo-Ming Chen, Zhi-Wei Zhou, Ying-Bo Chen, Yuan-Fang Li
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background The present meta-analysis was to explore the surgical and oncological outcomes of bursectomy for advanced gastric cancer (AGC). Methods Relevant studies that evaluated the role of bursectomy for AGC were comprehensively examined t
Externí odkaz:
https://doaj.org/article/8f0fdb2f3df14a6991905e8ced4d8ada
Autor:
Yun Wang, Yun-Fei Yuan, Hao-Cheng Lin, Bin-Kui Li, Feng-Hua Wang, Zhi-Qiang Wang, Pei-Rong Ding, Gong Chen, Xiao-Jun Wu, Zhen-Hai Lu, Zhi-Zhong Pan, De-Sen Wan, Peng Sun, Shu-Mei Yan, Rui-Hua Xu, Yu-Hong Li
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background Pathologic response is evaluated according to the extent of tumor regression and is used to estimate the efficacy of preoperative treatment. Several studies have reported the association between the pathologic response and clinica
Externí odkaz:
https://doaj.org/article/f909ecff8783437fa2422ee45ce26419